Quadratus Lumborum Block Versus Transversus Abdominis Block

NANot yet recruitingINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

June 20, 2024

Primary Completion Date

September 1, 2025

Study Completion Date

September 1, 2025

Conditions
Postoperative Pain
Interventions
OTHER

General anesthesia

General anesthesia with fentanyl, propofol and remifentanil.

OTHER

Transverse abdominal block

Transverse abdominal block with ropivacaine 0,25% 0,2 ml/kg at the end of general anesthesia with fentanyl, propofol and remifentanil

OTHER

Quadratus lumborum block

At the end of general anesthesia with fentanyl, propofol and remifentanil, patients will receive quadratus lumborum block with ropivacaine 0,25% 0,2 ml/kg

Trial Locations (1)

01246-903

Hospital das Clínicas - Faculdade de Medicina da Universidade de Sao Paulo, São Paulo

All Listed Sponsors
lead

University of Sao Paulo General Hospital

OTHER

NCT04367233 - Quadratus Lumborum Block Versus Transversus Abdominis Block | Biotech Hunter | Biotech Hunter